![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
EFFICACY AND SAFETY OF ELBASVIR/GRAZOPREVIR IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HCV GT 1, GT 4 AND GT 6 INFECTION (C-CORAL): A PHASE III RANDOMIZED MULTINATIONAL CLINICAL TRIAL
|
|
|
Reported by Jules Levin
APASL 2017 Feb 15-19 Shanghai, China
Lai Wei*, Eduard Burnevich; I-Shyan Sheen; Jeong Heo; Van Kinh Nguyen; Tawesak Tanwandee; Pin-Nan Cheng; Do Young Kim; Won Young Tak; Svetlana Kizhlo; Duan Zhongping; Cheng-Yuan Peng; Li Wen Liang; Barbara Evans; George Hanna; Eliav Barr; Michael Robertson; Paul Ingravallo, Rohit Talwani, Jacob George
*Peking University People's Hospital, Beijing, China
![0315171](../images/031517/031517-14/0315171.gif)
![0315172](../images/031517/031517-14/0315172.gif)
![0315173](../images/031517/031517-14/0315173.gif)
![0315174](../images/031517/031517-14/0315174.gif)
![0315175](../images/031517/031517-14/0315175.gif)
![0315176](../images/031517/031517-14/0315176.gif)
![0315177](../images/031517/031517-14/0315177.gif)
![0315178](../images/031517/031517-14/0315178.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|